Research fuels our mission to end cancer
Many of the greatest minds in cancer research are at MD Anderson. They're here because MD Anderson offers a unique environment that accelerates their ability to end cancer. They collaborate with other cancer experts – in different research areas and with the world's leading cancer doctors. Bright students and trainees contribute further to our dynamic research environment. Discoveries are fueled by vast research support and resources. Tomorrow's medicine is available to our patients first since we have the most cancer clinical trials in the world. These research efforts work in parallel to fight cancer through prevention, early diagnosis, effective therapies and scientific breakthroughs.
FY17 CPRIT Funding Statistics
in research grants
for early translational research
for individual investigator research
In November, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded MD Anderson with $22 million, reflecting the importance and impact of our research. Ten MD Anderson faculty received individual investigator awards for research projects ranging from nanotechnology to immunotherapy.Learn more
Departments, Labs and Institutes
MD Anderson has many parts, including departments, labs and institutes, but the sum of those parts is ending cancer. MD Anderson's reach is comprehensive when it comes to eliminating cancer.
Our laboratories cover the full breadth of cancer research. They’re led by some of the leading scientists and physicians in the world.
Scientists from different disciplines come together to focus on a common area in our research institutes.
Celebrating 75 years
A vision for the future of cancer care
Moon Shots Program
Inspired by an unprecedented era of scientific discovery a generation ago, MD Anderson launched the Moon Shots Program, an ambitious plan to make a giant leap in cancer research to benefit patients.Learn more about the Moon Shots Program
Solid tumor treatment
GI cancer research
Breast cancer research
Digital health event
New partnerships to promote innovative treatment approaches
MD Anderson recently announced strategic research collaborations with three biotech and pharmaceutical companies: Vescor LLC, EMD Serono and Affimed. Partnerships with these companies will facilitate cancer research and drug discovery for several cancer types.